Calibr at Scripps Research
Kit Bonin, PhD has a diverse work experience in the field of science communication, grant writing, medical science liaison, biochemistry, and research. They are currently serving as the Associate Director of Science Communication at Calibr at Scripps Research since 2022. Prior to this, they worked as a Grant Science Writer at The University of Connecticut Health Center from 2018 to 2022. They also served as a Medical Science Liaison Resource Developer at Genentech in 2017 and as a Group Leader and Senior Biochemist at Agrivida, Inc. from 2013 to 2017. Additionally, they have experience as a Medical Writer at Infusion Communications, a Project Lead and Research Scientist at Monsanto from 2005 to 2011, and as a Postdoctoral Fellow at Columbia University from 1999 to 2005.
Dr. Kit Bonin obtained their B.S. in Biology from the University of Rhode Island, where they studied from 1991 to 1995. They pursued further education and completed their PhD in Molecular and Cell Biology at the University of Connecticut from 1995 to 1999.
This person is not in any offices
Calibr at Scripps Research
1 followers
The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science. Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs. Our pipeline programs range from cancer to infectious diseases and from discovery to early clinical trial stages, all aimed at preventing disease and healing humans around the world. We bring together leaders in research, drug development, and business to answer important biological questions and develop new interventions to treat, cure, and prevent disease. Our infrastructure and expertise extend from high-throughput screening and protein engineering to pharmacology and clinical development. Calibr’s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 100 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr’s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal, or foundation partnerships.